Literature DB >> 7115440

Inhibitory effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: a reflection of antidepressant potency.

A J Azzaro, K T Demarest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7115440     DOI： 10.1016/0006-2952(82)90515-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Authors:  Torun Malmlöf; Kristin Feltmann; Åsa Konradsson-Geuken; Frank Schneider; Rudolf-Giesbert Alken; Torgny H Svensson; Björn Schilström
Journal:  J Neural Transm (Vienna)       Date:  2014-06-07       Impact factor: 3.575

Review 2.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

3.  Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.

Authors:  L G Hársing; E S Vizi
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

4.  Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.

Authors:  R T Coutts; T S Rao; G B Baker; R G Micetich; T W Hall
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.